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Haemophilus ducreyi, the etiologic agent of the sexually transmitted genital ulcer disease chancroid, has been
shown to associate with dermal collagen fibers within infected skin lesions. Here we describe NcaA, a previously
uncharacterized outer membrane protein that is important for H. ducreyi collagen binding and host colonization. An
H. ducreyi strain lacking the ncaA gene was impaired in adherence to type I collagen but not fibronectin (plasma or
cellular form) or heparin. The mutation had no effect on serum resistance or binding to HaCaT keratinocytes or
human foreskin fibroblasts in vitro. Escherichia coli expressing H. ducreyi NcaA bound to type I collagen, demon-
strating that NcaA is sufficient to confer collagen attachment. The importance of NcaA in H. ducreyi pathogenesis
was assessed using both swine and human experimental models of chancroid. In the swine model, 20% of lesions
from sites inoculated with the ncaA mutant were culture positive for H. ducreyi 7 days after inoculation, compared
to 73% of wild-type-inoculated sites. The average number of CFU recovered from mutant-inoculated lesions was also
significantly reduced compared to that recovered from wild-type-inoculated sites at both 2 and 7 days after
inoculation. In the human challenge model, 8 of 30 sites inoculated with wild-type H. ducreyi progressed to the
pustular stage, compared to 0 of 30 sites inoculated with the ncaA mutant. Together these results demonstrate that
the collagen binding protein NcaA is required for H. ducreyi infection.
Haemophilus ducreyi is the etiologic agent of the sexually
transmitted genital ulcer disease (GUD) chancroid. Chancroid
is rare in the United States and Western Europe. It is prevalent
in tropical resource-poor regions and is endemic in certain
areas of Africa and Asia (11, 38, 39, 47), where there is also a
significant confluence of chancroid infection and human im-
munodeficiency virus (HIV) type 1 seropositivity (17, 30, 40).
In these regions, case-control studies have shown that the
relative risk of acquiring HIV infection for GUD patients
ranged from an odds ratio of 3 to 18.2 (20, 49, 60). Per indi-
vidual sexual act, GUD produces a 4- to 23-fold enhancement
of HIV acquisition (22, 33), and GUD in an HIV-positive
person doubles the relative risk per coital act of viral transmis-
sion to an HIV-negative partner (22, 61). Furthermore, HIV-
positive chancroid patients often present ulcers that are more
severe, longer lasting, and more difficult to cure (31, 45). These
observations outline the strong synergistic relationship be-
tween GUD and HIV (23, 24). Aggressive control of chan-
croid, a prevalent and highly transmissible GUD, may have the
potential to curtail the global spread of HIV (34, 37, 42).
Chancroid presents as a painful genital ulcer with a ragged
erythematous border. This lesion emits a purulent exudate
replete with macrophages, neutrophils, T and B lymphocytes,
and bacteria (both H. ducreyi and other opportunistic species)
(32). H. ducreyi does not cause disseminated infection in
healthy or immunocompromised individuals and appears to be
well adapted to survive in the skin of its obligate human host
(59). However, the mechanism by which H. ducreyi colonizes
skin remains poorly understood. H. ducreyi attaches to the
HaCaT keratinocyte cell line in vitro (62), and this association
is dependent upon expression of the outer membrane protein
DsrA (15). DsrA also confers resistance to complement-medi-
ated killing by normal human serum (19). H. ducreyi lacking
DsrA is attenuated in both human and swine experimental
chancroid models (12), but it is not clear how the keratinocyte
attachment or serum resistance properties of DsrA specifically
contribute to this phenotype. H. ducreyi also adheres to human
foreskin dermal fibroblasts and forms microcolonies in vitro;
this aggregative-adhesive phenotype depends on expression of
the fimbria-like protein encoded by the flp gene cluster (41).
Human volunteers inoculated with an flp mutant display le-
sions that fail to progress from the papular to the pustular
stage, and live H. ducreyi was recovered from only 1 of 31 of
these sites (53), suggesting that the above-described phenotype
contributes to H. ducreyi survival in skin.
Despite the observation that H. ducreyi adheres to skin ep-
ithelial cells and fibroblasts in vitro, direct association between
H. ducreyi and these types of cells within the chancroid lesion
has not been proven. H. ducreyi was, however, shown to bind
the extracellular matrix (ECM) proteins fibronectin, laminin,
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and collagen types I and III in vitro (9). In early-stage lesions
derived from the human challenge model, H. ducreyi colocal-
ized with macrophages and neutrophils within the pustule and
also associated with fibrin and collagen in the dermis directly
beneath the pustule (8). These findings suggest that adherence
to ECM proteins, which comprise a major structural compo-
nent of skin, may be an important contributing factor in H.
ducreyi skin colonization.
We recently found that protection against H. ducreyi infec-
tion in the swine model of chancroid coincides with the emer-
gence of H. ducreyi-specific bactericidal serum antibodies and
that transfer of this immune serum protects naı̈ve pigs against
H. ducreyi challenge (16). Antibodies present in this immune
serum recognized a distinct subset of H. ducreyi outer mem-
brane proteins. Here we describe one of these proteins, termed
NcaA, and its role in mediating binding of H. ducreyi to colla-
gen binding and in H. ducreyi pathogenesis.
MATERIALS AND METHODS
Bacterial growth conditions. H. ducreyi strains were grown on chocolate agar
containing 1.5% Bacto agar, 2.5% brain heart infusion (BHI), 1% bovine hemo-
globin, 1% IsoVitaleX (Becton Dickinson, Cockeysville, MD), 5% newborn calf
serum, and 5% fetal bovine serum (Life Technologies, Inc., Rockville, MD) at
35°C in a humidified incubator with 5% CO2. Escherichia coli strains were
propagated in LB broth or agar at 37°C. Ampicillin, kanamycin, vancomycin, or
chloramphenicol was added to media when indicated to a final concentration of
100, 40, 3, or 1 g/ml, respectively.
Radioimmunoprecipitation of H. ducreyi outer membrane proteins. H. ducreyi
35000HP was grown overnight on chocolate agar as a confluent lawn, harvested,
and resuspended in phosphate-buffered saline (PBS). This suspension was added
to a precoated IODO-GEN tube (Pierce Biotechnology, Rockford, IL) with 1.0
mCi of 125NaI. Labeling was quenched after 3 min with an excess of GC medium
base broth. Surface-iodinated bacteria were washed and mixed with preimmune
or H. ducreyi-immune pig serum, incubated for 15 min at room temperature with
occasional mixing, again washed with PBS, and pelleted. The resulting cell pellet
was then resuspended in radioimmunoprecipitation buffer (2% Zwittergent 3-14,
50 mM Tris [pH 8.0], 5 mM EDTA, 0.15 M NaCl) and incubated with rocking for
30 min at 37°C. Insoluble matter was removed by centrifugation (5 min at 14,000 
g), and the supernatant containing solubilized antibody-labeled outer membranes
was mixed with protein G-agarose (Sigma Chemical, St. Louis, MO). After
overnight rocking at 4°C, the slurry was washed three times with radioimmuno-
precipitation buffer and once with distilled H2O. The resulting pellet was resus-
pended in Laemmli sample buffer containing -mercaptoethanol, boiled, and
resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE). Resolved bands of iodinated (outer membrane) proteins bound by
preimmune or H. ducreyi-immune pig serum were visualized by autoradiography.
Identification, cloning, and mutagenesis of ncaA. H. ducreyi outer membrane
proteins were resolved by SDS-PAGE and transferred to a polyvinylidene diflu-
oride membrane. Protein bands were excised and subjected to Edman degrada-
tion at the UNC Protein Sequencing & Peptide Synthesis Facility (University of
North Carolina, Chapel Hill). Amino acid sequences were compared using
EMBOSS pairwise alignment algorithms hosted by the European Bioinformatics
Institute. (http://www.ebi.ac.uk/emboss/align/index.html). The ncaA gene was
amplified by PCR from H. ducreyi 35000HP genomic DNA by using forward
primer 5CTAGGCTAATGAGAGGTATATCG3 and reverse primer 5TTGT
ACGCATCGCTTGTTCC3. The resulting product was cloned into pCR2.1
(Invitrogen, Carlsbad, CA) and was verified by automated DNA sequencing
(UNC Genome Analysis Facility, Chapel Hill, NC). To produce an inactivated
allele of ncaA, a 134-bp segment of ncaA between two NdeI sites was excised
and replaced with a chloramphenicol acetyltransferase gene (cat) cassette
derived from pUNCH40 (57). The cat-interrupted ncaA gene (ncaA::cat) was
subcloned into plasmid pRSM2072 (a gift of Robert S. Munson, Jr.), and the
resulting construct was used as a suicide vector to perform allelic exchange in
H. ducreyi as described by Bozue et al. (14). H. ducreyi 35000HP was trans-
formed with pRSM2072-ncaA::cat and plated on chloramphenicol to select
cointegrates. Cointegrates were then plated on medium containing chloram-
phenicol and X-Gal (5-bromo-4-chloro-3-indolyl--D-galactopyranoside) (40
g/ml) to counterselect for excision of the pRSM2072 vector backbone and the
wild-type ncaA allele. Southern blot and PCR analyses of the mutant confirmed
that a single copy of the cat cassette had been inserted into ncaA (data not
shown). Transcriptions of genes adjacent to the ncaA locus (Fig. 1) in 35000HP
and 35000HPncaA were found equivalent by reverse transcriptase PCR, showing
that ncaA inactivation did not exert a negative polar effect on local transcription.
To examine whether 35000HPncaA had phenotypes other than that caused by
the mutation, 35000HPncaA was compared to the master 35000HP stock used to
infect human volunteers. The phenotypes included comparisons of growth rates
in broth and outer membrane protein (OMP) and lipooligosaccharide (LOS)
profiles, as previously described (21). 35000HP and 35000HPncaA had similar
generation times in broth (data not shown). OMPs and LOSs from 35000HP and
35000HPncaA were analyzed by SDS-PAGE, followed by Coomassie blue and
silver staining. The OMP and LOS profiles demonstrated no difference between
the parent and the mutant (data not shown). Because NcaA is a low-abundance
protein as determined by Coomassie blue staining, ablation of NcaA protein
expression in the mutant strain was confirmed by Western blot analysis with H.
ducreyi-immune pig serum. Whole-cell lysates of 35000HP and 35000HPncaA
were heated in sample buffer containing SDS and -mercaptoethanol and then
resolved by SDS-PAGE and blotted to nitrocellulose. The blot was probed with
H. ducreyi-immune pig serum (1:1,000), followed by peroxidase-conjugated rab-
bit anti-pig immunoglobulin (1:32,000; Sigma Chemical, St. Louis, MO) and
chemiluminescence detection (SuperSignal Pico; Pierce Biotechnology, Rock-
ford, IL).
Serum susceptibility assay. Serum susceptibility assays were performed as
previously described (19). Briefly, bacteria grown on solid medium for 16 to 18 h
were collected and suspended in 2 ml of BHI, vortexed for 5 seconds, and
allowed to settle for 5 min. After settling, the upper 1 ml was removed and the
cell density was adjusted such that the final concentration of bacteria was ap-
proximately 1  103 to 5  103 CFU/ml. Bacteria were mixed with fresh or
heat-inactivated normal swine serum to a final concentration of 25% or 50%.
Following incubation for 45 min (35°C, 5% CO2), the bacterial suspensions were
plated to count viable CFU. Percent survival was calculated by dividing the
number of CFU from fresh serum by the number from heat-inactivated serum
and multiplying by 100. Assays were performed in triplicate and on three sepa-
rate days.
Fluorescein labeling of bacterial strains. Overnight cultures of H. ducreyi
grown on chocolate agar or of E. coli grown in LB broth were collected and
washed three times in PBS, followed by passage through a 30-gauge needle to
disperse large aggregates. Carboxyfluorescein diacetate succinimidyl ester (Mo-
lecular Probes, Eugene, OR) in dimethyl sulfoxide was added to a final concen-
tration of 12 M, and the suspension was incubated with gentle mixing at 35°C
for 25 min. H. ducreyi labeling reactions were quenched with an equal volume of
BHI medium supplemented with 1% IsoVitaleX (Becton Dickinson, Cock-
eysville, MD), 1% hemoglobin, (Becton Dickinson, Cockeysville, MD), and 10%
fetal bovine serum (Life Technologies, Rockville, MD). E. coli labeling reactions
were quenched by addition of bovine serum albumin to a final concentration of
1%. The resulting fluorescein-labeled bacteria were collected by centrifugation
at 1,040  g for 10 min and resuspended in LB (E. coli) or in BHI supplemented
with 1% IsoVitaleX and 1% hemoglobin (H. ducreyi). Bacteria were then incu-
bated for 40 to 60 min at 35°C with shaking. The doubling times of fluorescein-
labeled and unlabeled H. ducreyi were similar (data not shown).
Extracellular matrix protein attachment assay. White 96-well plates (Fluoro-
nunc; Nalge Nunc, Rochester, NY) were coated with bovine or human type I
collagen (Chondrex, Redmond, WA), human cellular fibronectin, or human
plasma fibronectin (Sigma-Aldrich, St. Louis, MO) diluted in collagen dilution
buffer (Chondrex, Redmond, WA) or 50 mM sodium carbonate, pH 9.6 (fi-
bronectins). Similar results were obtained in binding assays using bovine- and
human-derived type I collagens. Plates were incubated overnight at 35°C
FIG. 1. The H. ducreyi 35000HP ncaA locus and neighboring genes.
RNA transcripts of prolyl-tRNA ligase (proS, HD1919), ATP-depen-
dent DNA helicase (recG, HD1921), and RNA polymerase  subunit
(rpoZ, HD1923) were detected by reverse transcription-PCR and
found to be produced in both 35000HP and 35000HPncaA (in which
the ncaA gene is insertionally inactivated by cat as shown).
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(fibronectin) or 4°C (collagen), washed three times with PBS containing 0.05%
Tween 20, and blocked with 300 l of 0.5% bovine serum albumin (Sigma-
Aldrich, St. Louis, MO) in PBS for 2 hours at 35°C. Wells were washed three
times in PBS. Fluorescein-labeled or nonlabeled bacteria in BHI (200 l) were
added to appropriate wells. Separate aliquots of the bacterial suspensions were
serially diluted and plated to determine CFU input. After 4 h at 35°C, the wells
were washed three times with PBS containing 0.05% Tween 20, and 200 l of
PBS was added to all wells prior to reading fluorescence. Fluorescence emission
at 520 nm was measured following excitation at 490 nm, using a microplate
spectrometer (model LS50B; Perkin-Elmer Ltd., Beconsfield, Buckinghamshire,
England). Standard curves were established for each strain in each assay to allow
calculation of attached CFU from fluorescence intensity.
Animal care. Pigs were housed in an American Association for Accreditation
of Laboratory Animal Care-accredited P2 containment facility at North Carolina
State University College of Veterinary Medicine. Animals were sedated for all
procedures with 0.3 ml per 22.7 kg of body weight of an anesthetic formulation
consisting of: Telazol (tiletamine HCl [50 mg/ml] and zolazepam HCl [50 mg/ml];
Fort Dodge Laboratories, Fort Dodge, IA), 50 mg/ml ketamine HCl (Fort Dodge
Laboratories, Fort Dodge, IA), and 50 mg/ml xylazine (Miles Laboratories,
Shawnee Mission, KS). Atropine sulfate (Phoenix Scientific Inc., Joseph, MO)
was given at 0.5 to 1 ml to slow salivary and bronchial secretion. Pigs were
maintained in the same room but in separate enclosures during the course of the
study.
Virulence testing in pigs. Inoculum preparation, inoculation, and biopsy pro-
cedures were previously described (27, 52). Briefly, H. ducreyi grown on choco-
late agar was suspended in PBS and passed through a 30-gauge needle to
disperse aggregates. Multi-Test skin test applicators (Lincoln Diagnostics, De-
catur, Ill.) were loaded with 10 l of inoculum and pressed into the dorsal side
of the ear. Each round of inoculations entailed four to six application sites per
ear per strain tested. Biopsies of experimental lesions collected 2 and 7 days after
inoculation using 6-mm skin biopsy punches (Acuderm, Ft. Lauderdale, FL)
were minced and plated on chocolate agar containing vancomycin to detect
viable H. ducreyi within lesions.
Virulence testing in human volunteers. Healthy adult male and female volun-
teers over 18 years of age were recruited for the study. Subjects gave informed
consent for participation and for HIV serology, in accordance with the human
experimentation guidelines of the U.S. Department of Health and Human Ser-
vices and the Institutional Review Board of Indiana University-Purdue Univer-
sity of Indianapolis. The experimental challenge protocol, preparation and in-
oculation of the bacteria, calculation of the estimated delivered dose (EDD),
surface cultures, and clinical observations were done exactly as described previ-
ously (4, 5, 54, 55, 58). Each subject was inoculated on one arm with three
identical doses of the parent strain and on the other arm with three doses of
twofold serial dilutions of the mutant. Subjects were observed until they reached
a clinical end point, defined as either 14 days after inoculation, development of
a pustule that was either painful or greater than 4 mm in diameter, or resolution
of infection at all sites. Once a clinical end point was achieved, the code was
broken and sites with clinical disease, if present, were biopsied. The subjects were
then treated with two doses of oral ciprofloxacin (5, 55).
To confirm that the inocula were correct and that no phenotypic changes
occurred during infection, individual colonies from the inocula, surface cultures,
and biopsy specimens were picked, suspended in freezing medium, and frozen in
96-well plates. The colonies were scored for susceptibility to chloramphenicol. If
available, sufficient colonies (n  30) from an individual specimen were scored
so that there was a 95% probability that 11% of the colonies would have the
incorrect phenotype (1).
Statistical analysis. Data from the pig model were analyzed using SigmaStat
version 2.0 (Jandel Scientific, San Rafael, CA) and SAS version 9 (SAS Institute
Inc., Cary, NC). Numbers of viable wild-type and mutant H. ducreyi CFU recov-
ered from lesion biopsies were analyzed using Poisson regression. Percentages of
culture-positive biopsies were analyzed via logistic regression modeling of prob-
abilities of recovery. Both regression models were adjusted for variability among
pigs by using generalized estimating equations (GEE). Comparisons of papule
and pustule formation rates between the two strains in the human challenge
model were performed using a logistic regression model with GEE to account for
the correlation among sites within the same subject, as described previously (53).
The GEE sandwich estimate for the standard errors was used to calculate 95%
confidence intervals for these rates. When a rate was zero, the exact binomial
confidence intervals were calculated based on the number of subjects rather than
the number of sites. The z-significance test of two means was used to compare the
adherence of different strains of bacteria to type I collagen, and the t test was
used to determine the significance of NcaA-expressing E. coli bound to collagen.
RESULTS
Identification of a putative oligomeric coiled adhesin in H.
ducreyi. We recently demonstrated that pigs repeatedly in-
oculated with H. ducreyi develop a modest antibody-medi-
ated protective response against reinfection (16). Targets of
this antibody response were identified by immunoprecipitation
of 125I-labeled H. ducreyi OMPs with immune sera from mul-
tiply inoculated pigs. Seven distinct H. ducreyi outer membrane
proteins were precipitated exclusively by immune sera (data
not shown). One of these proteins, with an apparent molecular
mass of 100 kDa, was isolated and identified via N-terminal
amino acid sequencing and comparison to the published H.
ducreyi genome sequence. The N-terminal sequence, ITTES
IPT, matched predicted amino acids 21 to 28 of a previously
uncharacterized H. ducreyi OMP (hypothetical protein HD1920;
BLAST accession no. NP_874254) with a predicted molecular
mass of 33 kDa. We named this protein NcaA.
The NcaA amino acid sequence is similar to those of the
H. ducreyi OMP DsrA (25.1% identity and 42.6% similarity),
Yersinia enterocolitica YadA (23.0% identity and 39.9% sim-
ilarity), Moraxella catarrhalis UspA proteins (21.0 to 22.0%
identity and 35.6 to 39.3% similarity), and Escherichia coli Eib
(20.7 to 27.2% identity and 38.0 to 43.2% similarity) proteins.
These proteins have been described as oligomeric coiled ad-
hesins (Oca) (48), a subfamily of the type Vc surface-attached
oligomeric autotransporter family (25). They are typified by a
signature C-terminal 9-amino-acid stretch of alternating hy-
drophobic amino acids terminating with phenylalanine or tryp-
tophan which comprises an outer membrane localization mo-
tif. The C-terminal region of these proteins also appears to
mediate the formation of multimers that can remain stable
even when heated with detergent and reducing agents (48).
The disparity between the hypothetical molecular weight of
monomeric NcaA and its dramatically slower migration in
SDS-PAGE (Fig. 2) is consistent with similar proteins of this
nature. The sequence of the 79 C-terminal amino acids of
NcaA is 98% similar to the consensus Oca sequence and also
possesses the 9-amino-acid terminus motif. Oca proteins share
other properties in addition to the C-terminal signature se-
quence, including involvement in adherence, binding of ECM
proteins, and resistance to complement-mediated killing. These
common functions led us to investigate whether NcaA mediates
adherence to eukaryotic cells and ECM proteins.
Extracellular matrix protein binding properties of NcaA. To
determine whether NcaA binds ECM proteins, we compared
the ECM binding properties of wild-type H. ducreyi 35000HP
with those of a mutant unable to express NcaA due to inser-
tion-deletion inactivation of the ncaA gene. Fluorescein-la-
beled 35000HP and the ncaA mutant (35000HPncaA) were
incubated in ECM-coated microplate wells. Assays were per-
formed by incubating a bacterial suspension of constant density
in wells coated with a range of ECM concentrations from 0 to
80 g/ml. A minimum H. ducreyi density of 107 CFU/ml was
sufficient to ensure that binding saturation was achieved at the
highest ECM concentrations. Bacterial binding was deter-
mined by measuring the fluorescence intensity of each well
following incubation and washing and then relating that inten-
sity to an assay-specific standard curve correlating fluorescence
to CFU.
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Binding of the ncaA mutant strain to type I human collagen
was significantly less than that of its isogenic parent strain H.
ducreyi 35000HP (Fig. 3), with statistically significant differ-
ences in attachment at all ECM concentrations tested except
0.002 g/ml. In contrast, there was no difference in the level of
binding of 35000HP or 35000HPncaA to heparin (an analog of
the cell surface receptor heparan sulfate proteoglycan), plasma
fibronectin, or cellular fibronectin (data not shown). These
data indicate that NcaA promotes specific adherence to type I
collagen and not to related ECM proteins or cell surface ad-
hesion molecules.
To determine if NcaA was sufficient to confer adherence to
type I collagen, we tested the binding phenotype of E. coli
expressing H. ducreyi NcaA. E. coli TOP10 containing the ncaA
gene in pCR2.1 (TOP10 pncaA) or with pCR2.1 vector alone
(TOP10 pCR2.1) was fluorescently labeled and incubated in
microplate wells coated with type I collagen. Approximately
106 TOP10 pncaA CFU bound to collagen following incuba-
tion with 8  106 CFU, whereas fewer than 100 TOP10 pCR2.1
CFU remained after incubation with 3.2  107 CFU (Fig. 4).
TOP10 pncaA did not bind wells coated with plasma fibronec-
tin (data not shown). These data indicate that NcaA is both
necessary and sufficient to elicit specific association with type I
collagen.
Effect of NcaA expression on H. ducreyi serum resistance
and adherence to keratinocytes and foreskin fibroblasts. The
Oca proteins UspA2, (2) and YadA (7, 35) and the Eib pro-
teins A, C, D, E, and F (50, 51) impart resistance in their
respective organisms to complement-mediated killing in the
absence of opsonizing antibody and have also been shown to
mediate binding to host receptors. NcaA has significant amino
acid sequence similarity to DsrA, an H. ducreyi outer mem-
FIG. 2. Immunoblot of H. ducreyi 35000HP (wild type [wt]) and
35000HPncaA (ncaA) whole-cell lysates with immune pig serum. The
arrow indicates the position of an apparently multimeric form of
NcaA, which migrated as a 100-kDa protein despite heating in the
presence of SDS and -mercaptoethanol. Other bands represent the
constellation of H. ducreyi proteins recognized by polyclonal immune
pig serum. Numbers indicate molecular mass standards in kilodaltons.
The immunoblot film was scanned with an HP ScanJet 3970. The
contrast of the scanned image was adjusted using the auto contrast
command within Adobe Photoshop CS, and annotations were added
with Adobe Illustrator CS.
FIG. 3. Adherence of fluorescently labeled ncaA mutant (gray plot)
or wild-type (black dashed plot) H. ducreyi to immobilized type I
collagen. Adherence at each concentration of collagen was tested eight
times in each assay, and adherence assays were performed three times
for each strain. The data presented were averaged from the three
assays, and error bars depict standard errors of the means. All values
except the lowest (0.002 g/ml collagen) were significantly different
(all P 	 0.05).
FIG. 4. Impact of NcaA expression on E. coli adherence to type I
collagen. Fluorescently labeled E. coli TOP10 containing empty vector
or ncaA plasmids was incubated in microplate wells coated with 40
g/ml bovine type I collagen. Data presented are mean E. coli CFU
bound (error bars show standard errors of the means) following incu-
bation with 1.6  107 and 8.0  106 vector- or ncaA-containing CFU,
respectively.
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brane protein and Oca protein that confers resistance to killing
by normal human serum (19) as well as attachment to keratino-
cytes (15). We therefore tested the sensitivity of 35000HPncaA to
normal human serum. The serum-sensitive strain H. ducreyi
FX517 (35000HPdsrA) was effectively killed by 25% and 50%
naı̈ve pig serum with complement, whereas 35000HP and
35000HPncaA were both resistant to complement-mediated
killing (Fig. 5). We also determined if NcaA mediates adhesion
to keratinocytes and fibroblasts, which are the predominant
cell types in skin. Both 35000HP and 35000HPncaA adhered to
HaCaT cells, a human keratinocyte cell line (13), and HS27
cells, a human foreskin fibroblast cell line (1634-C; American
Type Culture Collection, Manassas, VA) (data not shown).
From these findings we concluded that NcaA neither contrib-
utes to serum resistance nor promotes adhesion to cultured
skin fibroblasts or keratinocytes.
NcaA expression is necessary for virulence in the swine
model of chancroid infection. To determine if NcaA is impor-
tant in skin lesion formation in vivo, we inoculated pigs with
35000HP or 35000HPncaA and assessed bacterial recovery
from biopsies taken 2 or 7 days postinoculation (p.i.). These
data were generated from 14 animals across six experimental
iterations. The percentages of biopsies containing viable H.
ducreyi at day 2 p.i. were not significantly different for sites
inoculated with 35000HP or 35000HPncaA (60.3% versus 56.4%
culture positive, respectively) (Table 1). However, there was a
statistically significant difference (P 	 0.0001) between the
proportions of culture-positive biopsies taken at day 7 p.i. from
sites inoculated with 35000HP (72.9%) or 35000HPncaA
(20.0%). Despite similar numbers of culture-positive biopsies
at day 2 p.i., the average number of CFU recovered from
35000HP-inoculated sites was over fivefold higher than the
number recovered from mutant-inoculated sites (161.0 versus
30.4 CFU per biopsy). This span increased to over 24-fold at
day 7 p.i. (146.8 versus 6.1). Differences in the number of CFU
recovered per biopsy were statistically significant (P 	 0.0001)
at both days of biopsy. We also inoculated pigs with the
cointegrate merodiploid strain generated during construc-
tion of 35000HPncaA in order to determine if the phenotype
of 35000HPncaA was due to a spurious attenuating mutation
rather than the targeted inactivation of the ncaA locus. Unlike
35000HPncaA, the cointegrate was recovered from pig ear
lesions with similar frequency and in similar amounts as wild-
type 35000HP at days 2 and 7 p.i. (Table 1), demonstrating that
this strain is not attenuated.
Human inoculation experiments. The human challenge
model allowed us to assess the importance of NcaA in estab-
lishing infection in the natural host of H. ducreyi. An escalating
dose-response study was used to compare the virulences of
35000HP and 35000HPncaA. Eleven healthy adults (seven fe-
males and four males; age range, 20 to 53 years; mean age 

standard deviation, 38.6 
 11.3 years) volunteered for the
study. One subject (no. 245) withdrew prior to inoculation. In
the first iteration, one subject was inoculated at three sites with
an EDD of 34 CFU of the parent strain and at three sites with
EDDs of 23, 46, and 92 CFU of the mutant. Papules developed
at two of three sites inoculated with the parent and at two of
three sites inoculated with the mutant, but all the papules
resolved (Table 2). In the second iteration, three subjects were
inoculated at three sites with an EDD of 85 CFU of the parent
and at three sites with EDDs of 31, 62, and 124 CFU of the
mutant. Papules developed at four of nine sites inoculated with
the parent strain and at five of nine sites inoculated with the
mutant (Table 2). A pustule developed at one parent site,
while all mutant sites resolved (Table 2). In the third iteration,
the subjects were inoculated with an EDD of 92 CFU of the
parent and with EDDs of 74, 147, and 294 CFU of the mutant.
Papules developed at all nine parent sites and at seven of nine
mutant sites (Table 2). Pustules developed at six of nine parent
sites, while all mutant papules resolved. In the fourth iteration,
FIG. 5. Serum sensitivity of H. ducreyi mutants. Survival of wild-
type (black bars), ncaA mutant (white bars), and dsrA mutant (gray
bars) H. ducreyi after incubation in 25% or 50% normal pig serum
(NPS) is shown. Serum survival was assayed in triplicate in three
independent experiments (error bars show standard errors of the
means).
TABLE 1. Response to experimental inoculation of H. ducreyi 35000HP, 35000HPncaA, and 35000HPncaA merodiploid in pigs
Strain
H. ducreyi CFU per lesion biopsy a at day p.i.: % H. ducreyi-positive biopsiesb at day p.i.:
2 7 2 7
35000HP 161.0 (90.5–497.4) 146.8 (111.2–320.8) 60.3 (30.9–75.7) 72.9 (57.5–96.8)
35000HPncaA 30.4 (19.5–82.3)c 6.1 (2.2–28.6)c 56.4 (31.6–68.7) 20.0 (17.1–61.7)c
35000HPncaA merodiploid 280.9 (181.0–1390.2) 320.3 (148.3–1080.7) 70.0 (24.9–85.4) 75.0 (64.3–95.7)
a Values indicate the observed mean CFU per biopsy, with 95% confidence intervals in parentheses, as modeled by poisson regression and GEE adjustment to
account for variability between pigs.
b Values indicate the observed mean proportion of biopsies harboring viable H. ducreyi, with 95% confidence intervals in parentheses, as modeled by logistic
regression and GEE adjustment.
c Significantly different (P 	 0.0001) from values for wild-type or merodiploid lesions on same day postinoculation.
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the subjects were inoculated with an EDD of 140 CFU of the
parent and EDDs of 490, 960, and 1,920 CFU of the mutant.
Papules developed at eight of nine sites inoculated with the
parent and at eight of nine sites inoculated with the mutant
(Table 2). A pustule developed at one parent site, while all
mutant sites resolved (Table 2).
The cumulative results for the four iterations showed that
papules developed at 76.7% (95% confidence interval [CI],
55.9% to 97.4%) of sites inoculated with 35000HP and at
74.3% (95% CI, 55.3% to 91.3%) of sites inoculated with
35000HPncaA. Overall, pustules formed at 8/30 (26.7%; 95%
CI, 6.4% to 46.9%) sites inoculated with 35000HP, compared
to 0 of 30 (0%; 95% CI, 0% to 25.9%) sites inoculated with
35000HPncaA (P  0.005). Thus, the mutant was impaired in
its ability to form pustules compared to the parent.
For the four parent and four mutant broth cultures used to
prepare the inocula, all 192 parent colonies and all 192 mutant
colonies tested were phenotypically correct (mutant, chloram-
phenicol resistant [Cmr]; parent, Cms). Of the 30 sites that
were inoculated with the parent, 6 (20%) yielded at least one
positive surface culture, while 0 of 18 mutant sites yielded a
positive surface culture. All colonies obtained from surface
cultures (n  346) and biopsy specimens (n  9) from parent
sites were phenotypically correct (Cms). Thus, all tested colo-
nies from the inocula, surface cultures, and biopsy specimens
had the expected phenotype. We were unable to test the mero-
diploid strain for complementation of the 35000HPncaA phe-
notype because inoculation of human volunteers with strains
that harbor plasmids is not permitted.
DISCUSSION
During the course of identifying targets of immune serum
that conferred protection against H. ducreyi infection in the
swine chancroid model, we found that at least one of the
antibodies bound a previously uncharacterized outer mem-
brane protein. We named this protein NcaA because our find-
ings have shown it to be necessary for collagen association in
H. ducreyi. The sequence of the C-terminal 79 amino acids of
NcaA is similar to that of the oligomeric coiled adhesin (Oca)
subfamily of autotransporter proteins. Oca proteins form oli-
gomeric lollipop-shaped surface projections on the bacterial
outer membrane, consisting of N-terminal head and neck do-
mains followed by a coiled-coil stalk and a YadA-like C-ter-
minal domain that anchors the protein in the outer membrane
(28, 48). The amino acid sequence of NcaA is consistent with
this proposed structure, but its three-dimensional structure has
not been determined. Oca proteins also migrate as heat-stable
oligomers during SDS-PAGE. This peculiarity is thought to
reflect the avid oligomerization property of these proteins on
the bacterial surface (3, 19, 36, 48, 51). YadA exists as a trimer
both when anchored to the bacterial outer membrane and
during migration through SDS-PAGE (48). Monomeric NcaA
has a predicted molecular mass of 33 kDa but shows an ap-
parent size of 100 kDa in SDS-PAGE (Fig. 2), suggesting
that it also oligomerizes, though it is not known how many
NcaA monomers assemble to form a functional complex.
Chancroid transmission occurs when H. ducreyi penetrates
the keratinized skin surface layer and colonizes the dermis or
epidermis of the skin. Type I collagen is the predominant
structural component of skin (6), and H. ducreyi is found as-
sociated with type I collagen in the dermis of biopsy samples
collected from human volunteers 48 h postinoculation (8).
Other ECM attachment studies also demonstrated that H.
ducreyi binds to immobilized type I collagen in vitro (1, 9). Our
results indicate that specific association of H. ducreyi with type
I collagen is mediated by NcaA. Collagen binding is a crucial
factor in the pathogenesis of other organisms that inhabit skin
during infection. For example, loss of YadA-mediated collagen
binding is associated with loss of Yersinia enterocolitica viru-
lence in a mouse model of infection (56). In addition, the
Staphylococcus aureus collagen adhesin Cna is required for
virulence in multiple animal models of infection (18, 26, 44,
46). Our finding that NcaA binds collagen is consistent with the
nature of H. ducreyi as a dermal pathogen.
Our in vitro experiments showed that NcaA neither medi-
ates adherence to cultured skin cells nor confers resistance to
complement-mediated killing. We also demonstrated that
NcaA is necessary and sufficient for bacterial association with
type I collagen. Bacterial adherence to host tissues is generally
considered to be an essential step in establishing infection (10,
43). Our studies here illustrate that adhesins mediating asso-
ciation of bacteria with structural ECM proteins in contrast to
adherence to host cells can also be important virulence deter-
minants. NcaA appears to have such a role in H. ducreyi patho-
TABLE 2. Human volunteer response to inoculation of live
H. ducreyi strainsa










244 F 5 35000HP 2 2
35000HPncaA 2 2
243 F 9 35000HP 3 1 2
35000HPncaA 2 2
247 M 3 35000HP 1 1
35000HPncaA 0
248 F 5 35000HP 0
35000HPncaA 2 2
249 M 8 35000HP 3 1 2
35000HPncaA 2 2
250 F 7 35000HP 3 3
35000HPncaA 3 3
251 M 8 35000HP 3 2 1
35000HPncaA 3 3
242 F 6 35000HP 3 3
35000HPncaA 3 3
252 F 9 35000HP 3 1c 1
35000HPncaA 3 3
253 F 5 35000HP 2 2
35000HPncaA 2 2
a Volunteer 244 was inoculated in iteration 1. Volunteers 243, 247, and 248
were inoculated in iteration 2. Volunteers 249, 250, and 251 were inoculated in
iteration 3. Volunteers 242, 252, and 253 were inoculated in iteration 4.
b M, male; F, female.
c One site remained a papule at the time the subject reached the end point.
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genesis. In pigs, the ncaA mutant was recovered from signifi-
cantly fewer lesions than the wild type. In human volunteers,
the ncaA mutant was unable to form pustules, making NcaA
the seventh H. ducreyi protein shown to be essential for viru-
lence in the native human host (4, 12, 21, 29, 53). Whereas
these findings demonstrate that NcaA is required for infection
of humans and pigs, we are conducting further studies to elu-
cidate the collagen binding property of NcaA and to determine
whether it is directly responsible for the contribution of NcaA
to H. ducreyi pathogenesis. We are also determining if an
antibody response against NcaA can confer protection against
H. ducreyi infection.
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